Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126202221 | 12620222 | 1 | I | 201507 | 20160721 | 20160803 | 20160803 | EXP | GB-MHRA-EYC 00142587 | GB-TEVA-679677ACC | TEVA | 24.00 | YR | Y | 69.85000 | KG | 20160804 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126202221 | 12620222 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 10-30MG | Y | U | 77232 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126202221 | 12620222 | 1 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126202221 | 12620222 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126202221 | 12620222 | Activities of daily living impaired | |
| 126202221 | 12620222 | Aphasia | |
| 126202221 | 12620222 | Impaired work ability | |
| 126202221 | 12620222 | Muscle twitching | |
| 126202221 | 12620222 | Paralysis | |
| 126202221 | 12620222 | Petit mal epilepsy | |
| 126202221 | 12620222 | Seizure | |
| 126202221 | 12620222 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126202221 | 12620222 | 1 | 201503 | 0 |